Linpeng Yao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Linpeng Yao has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Feng Chen
Department of Radiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
3 shared publications Peipei Yu
Department of Radiology, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, Zhejiang 310003, China
2 shared publications- Xing Xue
Department of Radiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
2 shared publications - Yicheng Ni
National Platform for Medical Engineering & Education Integration (NMEE) Zhongda Hospital Southeast University Nanjing China
2 shared publications - Chenchen Dai
Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, China
1 shared publication - Feng Chen1 shared publication
Latest Publications
- Top Cited Papers
- 1 May 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 311 (2) , e232178
Deep Learning Assessment of Small Renal Masses at Contrast-enhanced Multiphase CT
A deep learning algorithm based on contrast-enhanced multiphase CT demonstrated good performance for characterizing small (≤3 cm) renal masses as benign lesions.
- 1 May 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 311 (2) , e232178
Top Cited PapersDeep Learning Assessment of Small Renal Masses at Contrast-enhanced Multiphase CT
A deep learning algorithm based on contrast-enhanced multiphase CT demonstrated good performance for characterizing small (≤3 cm) renal masses as benign lesions.
- Open Access
- 28 August 2021
- Published by Wiley in Contrast Media & Molecular Imaging
- Vol. 2021, 1
Corrigendum to “Evans Blue Dye: A Revisit of Its Applications in Biomedicine”
[This corrects the article DOI: 10.1155/2018/7628037.].
- 28 August 2021
- Published by Wiley in Contrast Media & Molecular Imaging
- Vol. 2021, 1
Open AccessCorrigendum to “Evans Blue Dye: A Revisit of Its Applications in Biomedicine”
[This corrects the article DOI: 10.1155/2018/7628037.].
- Open Access
- 13 June 2018
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-9
Use of a Radiomics Model to Predict Tumor Invasiveness of Pulmonary Adenocarcinomas Appearing as Pulmonary Ground-Glass Nodules
Background. It is important to distinguish the classification of lung adenocarcinoma. A radiomics model was developed to predict tumor invasiveness using quantitative and qualitative features of pulmonary ground-glass nodules (GGNs) on chest CT. Materials and Methods. A total of 599 GGNs [including 202 preinvasive lesions and 397 minimally invasive and invasive pulmonary adenocarcinomas (IPAs)] were evaluated using univariate, multivariate, and logistic regression analyses to construct a radiomics model that predicted invasiveness of GGNs. In primary cohort (comprised of patients scanned from August 2012 to July 2016), preinvasive lesions were distinguished from IPAs based on pure or mixed density (PM), lesion shape, lobulated border, and pleural retraction and 35 other quantitative parameters (P Results. The model showed good discrimination between preinvasive lesions and IPAs with an area under curve (AUC) of 0.76 [95% CI: 0.71 to 0.80] in ROC curve for the primary cohort. The nomogram also demonstrated good discrimination in the validation cohort with an AUC of 0.79 [95% CI: 0.71 to 0.88]. Conclusions. For GGNs, PM, lobulated border, pleural retraction, age, and FD were features discriminating preinvasive lesions from IPAs. The radiomics model based upon PM and FD may predict the invasiveness of pulmonary adenocarcinomas appearing as GGNs.
- 13 June 2018
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-9
Open AccessUse of a Radiomics Model to Predict Tumor Invasiveness of Pulmonary Adenocarcinomas Appearing as Pulmonary Ground-Glass Nodules
Background. It is important to distinguish the classification of lung adenocarcinoma. A radiomics model was developed to predict tumor invasiveness using quantitative and qualitative features of pulmonary ground-glass nodules (GGNs) on chest CT. Materials and Methods. A total of 599 GGNs [including 202 preinvasive lesions and 397 minimally invasive and invasive pulmonary adenocarcinomas (IPAs)] were evaluated using univariate, multivariate, and logistic regression analyses to construct a radiomics model that predicted invasiveness of GGNs. In primary cohort (comprised of patients scanned from August 2012 to July 2016), preinvasive lesions were distinguished from IPAs based on pure or mixed density (PM), lesion shape, lobulated border, and pleural retraction and 35 other quantitative parameters (P Results. The model showed good discrimination between preinvasive lesions and IPAs with an area under curve (AUC) of 0.76 [95% CI: 0.71 to 0.80] in ROC curve for the primary cohort. The nomogram also demonstrated good discrimination in the validation cohort with an AUC of 0.79 [95% CI: 0.71 to 0.88]. Conclusions. For GGNs, PM, lobulated border, pleural retraction, age, and FD were features discriminating preinvasive lesions from IPAs. The radiomics model based upon PM and FD may predict the invasiveness of pulmonary adenocarcinomas appearing as GGNs.
- Top Cited PapersOpen Access
- 22 April 2018
- Published by Wiley in Contrast Media & Molecular Imaging
- Vol. 2018, 1-10
Evans Blue Dye: A Revisit of Its Applications in Biomedicine
Evans blue (EB) dye has owned a long history as a biological dye and diagnostic agent since its first staining application by Herbert McLean Evans in 1914. Due to its high water solubility and slow excretion, as well as its tight binding to serum albumin, EB has been widely used in biomedicine, including its use in estimating blood volume and vascular permeability, detecting lymph nodes, and localizing the tumor lesions. Recently, a series of EB derivatives have been labeled with PET isotopes and can be used as theranostics with a broad potential due to their improved half-life in the blood and reduced release. Some of EB derivatives have even been used in translational applications in clinics. In addition, a novel necrosis-avid feature of EB has recently been reported in some preclinical animal studies. Given all these interesting and important advances in EB study, a comprehensive revisiting of EB has been made in its biomedical applications in the review.
- 22 April 2018
- Published by Wiley in Contrast Media & Molecular Imaging
- Vol. 2018, 1-10
Top Cited PapersOpen AccessEvans Blue Dye: A Revisit of Its Applications in Biomedicine
Evans blue (EB) dye has owned a long history as a biological dye and diagnostic agent since its first staining application by Herbert McLean Evans in 1914. Due to its high water solubility and slow excretion, as well as its tight binding to serum albumin, EB has been widely used in biomedicine, including its use in estimating blood volume and vascular permeability, detecting lymph nodes, and localizing the tumor lesions. Recently, a series of EB derivatives have been labeled with PET isotopes and can be used as theranostics with a broad potential due to their improved half-life in the blood and reduced release. Some of EB derivatives have even been used in translational applications in clinics. In addition, a novel necrosis-avid feature of EB has recently been reported in some preclinical animal studies. Given all these interesting and important advances in EB study, a comprehensive revisiting of EB has been made in its biomedical applications in the review.